phylogica ltd (PYC) Details

Phylogica Limited, a biotechnology company, engages in the discovery and development of peptide based therapeutic candidates in Australia. The company provides drug discovery services to the pharmaceutical industry utilizing its Phylomer libraries and screening methodologies. Its proprietary Phylomer libraries contain various peptides that represent a source of biologically active drug leads for a range of intracellular and extracellular disease targets; and Phylomer peptides are bioactive fragments of naturally occurring proteins, which are encoded in the genomes of evolutionary diverse microbes. The company’s Phylomer peptides include protein interactions that promote various diseases, such as infectious diseases, cancer, autoimmunity, and heart diseases. It has approximately 16 patent families comprising multiple granted/allowed patents in the United States and Australia, which cover methods of making the Phylomer libraries, methods of screening them and composition-of-matter claims for Phylomer libraries, and individual Phylomer peptides discovered for therapeutic and diagnostic applications. The company is based in Subiaco, Australia.

phylogica ltd (PYC) Top Compensated Officers